Mercado de Polymarket
Prediction market
Track current outcome prices, market depth, volume, liquidity, and recent trades for Prediction market.
Proximo
- Probabilidad
- 32%
- Liquidez
- $1.56K
- Mejor compra
- 1%
- Mejor venta
- 99%
- Spread
- 98%
- Ultimo trade
- 32%
Outcomes
Resultados del mercado
Precio en vivo
Precio y liquidez
Compra, venta, punto medio, spread y profundidad actuales para este resultado.
- Mejor compra
- 1%
- Mejor venta
- 99%
- Punto medio
- 50%
- Spread
- 98%
- Ultimo trade
- 32%
- Profundidad
- 1078,87 / 478,35
Historial de precios
Esperando historial de precios
Historial no disponible
Compras
| Precio | Tamano |
|---|---|
| 1% | 115 |
| 18% | 300 |
| 26% | 134.61 |
| 28% | 49 |
| 30% | 89.81 |
| 31% | 89.81 |
| 32% | 30 |
| 54% | 18.64 |
Ventas
| Precio | Tamano |
|---|---|
| 99% | 115 |
| 98% | 55,27 |
| 97% | 13,06 |
| 95% | 27 |
| 94% | 27 |
| 93% | 54 |
| 92% | 30 |
| 72% | 47,28 |
Trades
Trades recientes
Latest visible trades for this market.
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?Yes 68% 16.66 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 30% 5.66 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?Yes 71% 4.86 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 37% 30 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?Yes 62% 6.45 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?Yes 59% 25.42 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 33.1% 140 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 57% 7 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 57% 54 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 44% 8 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 40% 30 shares
- FDA approves GSK & Spero Therapeutics' Tebipenem HBr?No 36.2% 151 shares